Treatment Effectiveness
User reported effectiveness ratings Gabapentin (Neurontin) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Chronic Pain Syndrome | 0% | 20% | 0% | 20% | 60% | 5 |
| Fibromyalgia | 6% | 25% | 15% | 39% | 15% | 195 |
| Menopause | 0% | 17% | 17% | 67% | 0% | 6 |
| Neuropathy | 4% | 24% | 13% | 44% | 15% | 71 |
| Peripheral Neuropathy | 4% | 39% | 4% | 48% | 4% | 23 |
| Vulvodynia | 7% | 25% | 4% | 58% | 5% | 201 |
Side Effects
User-reported side effects of Gabapentin (Neurontin)
| Side Effect | Percent of Reports Gabapentin (Neurontin) |
|---|---|
| Diarrhea | 15% |
| Constipation | 27% |
| Dry Mouth | 37% |
| Heartburn | 17% |
| Back or Joint Pain | 26% |
| Diarhea | 12% |
| Difficulty Concentrating or Paying Attention | 54% |
| Dizziness | 47% |
| Double or Blurred Vision | 24% |
| Drowsiness | 61% |
| Ear Pain | 11% |
| Fever | 5% |
| Memory Problems | 49% |
| Mental Slowness | 46% |
| Red, Itchy Eyes (Sometimes With Swelling or Discharge) | 11% |
| Runny Nose, Sneezing, Cough, Sore Throat, or Flu-Like Symptoms | 15% |
| Shaking of a Part of Your Body That You Cannot Control | 15% |
| Speech Problems | 22% |
| Strange or Unusual Thoughts | 23% |
| Swelling of the Hands, Feet, Ankles, or Lower Legs | 22% |
| Tiredness or Weakness | 58% |
| Unsteadiness | 39% |
| Unwanted Eye Movements | 10% |
| VAGINAL ODOR | 6% |
| Vomiting | 5% |
| Water Retension | 12% |
| Water Retention | 12% |
| Weight Gain | 34% |
| "High" or Elevated Mood | 16% |
| Anxiety / Nervousness | 31% |
| Headache | 29% |
| Nausea | 22% |
Outcomes
Below is the degree of change seen after Gabapentin (Neurontin) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Gabapentin (Neurontin) Info
| Property | Value |
|---|---|
| Variable Name | Gabapentin (Neurontin) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-05-04 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 93651 |